Meeting Banner
Abstract #2948

Investigation of Lithium Distribution in the Rat Brain ex vivo using Lithium-7 Magnetic Resonance Imaging at 17 Tesla

Anne-Sophie Hanak1, Jacques Andrew Stout2, Lucie Chevillard1, Boucif Djemaï2, Patricia Risède1, Michel Luong2, Eric Giacomini2, Joel Poupon3, David André Barrière2,4, Frank Bellivier1,5, Bruno Mégarbane1,5, and Fawzi Boumezbeur2

1INSERM UMR-S 1144, Universités Paris-Descartes & Paris-Diderot, Paris, France, 2Neurospin, CEA, Université Paris-Saclay, Gif-sur-Yvette, France, 3APHP, GH Saint-Louis-Lariboisière-Fernand Widal, Laboratoire de Toxicologie biologique, Paris, France, 4Inserm UMR-S 894, Université Paris-Descartes, Paris, France, 5APHP, GH Saint-Louis-Lariboisière-Fernand Widal, Réanimation Médicale et Toxicologique, Paris, France

Lithium (Li) is the first-line mood stabilizer to treat bipolar disorder patients. However, its mechanisms of action and transport across the blood-brain barrier remain poorly understood. In this study, we aimed at mapping ex vivo the cerebral Li distribution of rats treated for 28 days with Li2CO3 using 7Li-MRI at 17.2 Tesla. Using a phantom replacement approach, MRI-derived Li concentrations were calculated and validated by comparison to inductively coupled plasma-mass spectrometry (ICP-MS) measurements. Lithium distributions were uneven (normalized lithium content ranging from 0.7 to 1.4) and symmetrical with consistently lower concentrations in the metencephalon and higher ones in the cortex.

This abstract and the presentation materials are available to members only; a login is required.

Join Here